KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer

Clinical trial NCT05027867 · TERMINATED

Trial details

NCT number: NCT05027867
Sponsor: Kartos Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer Small Cell Lung Carcinoma Small Cell Lung Cancer Extensive Stage Small Cell Lung Cancer Recurrent

Start date: 2021-12-06
Primary completion: 2022-08-26
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.